FIELD: medicine.
SUBSTANCE: invention refers to medicine. What is described is a core-coating implanted device providing a release profile of a biologically active agent, which can be adapted to a specific therapy. The device is characterised by one or more flanges extending from an inner core at least partially to an outer coating.
EFFECT: depending on a specific design of this implanted device, it is possible to obtain a number of release profiles of a biologically active agent, which can be adapted to a specific therapy.
10 cl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| IMPLANTED DEVICES WITH VARIOUS VERSIONS OF BIOLOGICALLY ACTIVE INGREDIENT LOADING | 2010 |
|
RU2545865C2 |
| METHODS AND COMPOSITIONS CONTAINING CLONIDINE, APPLICABLE FOR TREATING POSTOPERATIVE PAIN | 2009 |
|
RU2510263C2 |
| EMULSION FOR MICROENCAPSULATION CONTAINING BIODEGRADABLE SURFACTANT BLOCK COPOLYMERS AS STABILIZERS | 2011 |
|
RU2617057C2 |
| COMPOUNDS CONTAINING CLONIDINE IN DEGRADABLE POLYMER | 2009 |
|
RU2494731C2 |
| BIOABSORBABLE MULTILAYER EXPANDING GRAFT FOR NASAL VALVE | 2012 |
|
RU2585135C2 |
| CONTROLLED RELEASE THERAPEUTIC AGENTS CONTAINING PEPTIDES | 2009 |
|
RU2543327C2 |
| PHARMACEUTICAL COMPOSITIONS WITH A SELECTED DURATION OF RELEASE | 2017 |
|
RU2756514C1 |
| DEGRADABLE REMOVABLE IMPLANT FOR CONTINUOUS RELEASE OF ACTIVE COMPOUND | 2010 |
|
RU2593790C2 |
| IMPLANTABLE DEVICE WITH INCREASED DRUG DELIVERY AREA | 2018 |
|
RU2810457C2 |
| DRUG-ELUTING STENT AND METHOD FOR PRODUCTION THEREOF | 2021 |
|
RU2775427C1 |
